the Safety and Efficacy of N-acetyl Cysteine and Lactobacillus in Children With Drug-Resistant Epilepsy
Status:
Not yet recruiting
Trial end date:
2024-08-01
Target enrollment:
Participant gender:
Summary
This study aims at investigating the possible efficacy and safety of Lactobacillus probiotic
or N-acetyl cysteine as adjuvant therapy in the treatment of drug-resistant epilepsy